4744.TWO · CVC
Taiwan · RS rating 59 · As of 2026-10-08
| Price | 28.55 TWD |
|---|---|
| 1-day change | +0.3% |
| RS rating (overall / 1M / 3M / 12M) | 59 / 72 / 70 / 51 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 29 / 23 / 20 |
| Industry group (rank) | Medical-Biomed/Biotech (53) |
| EPS growth Q/Q | -45.5% |
| Sales growth Q/Q | -20.4% |
| Distance from 52-week high | +26.6% |
| Market cap (USD) | $49.2M |